CAPTRUST Financial Advisors’s Nuvation Bio NUVB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$119K	Sell	27,751 -708	-2%	-$3.94K	﹤0.01%	2784
2025 Q4	$255K	Sell	28,459 -40	-0.1%	-$248	﹤0.01%	2365
2025 Q3	$105K	Buy	28,499 +12,300	+76%	+$33.5K	﹤0.01%	2504
2025 Q2	$31.6K	Buy	+16,199	New	+$33.7K	﹤0.01%	2460
2022 Q3	–	Sell	-263	Closed	-$1K	–	3351
2022 Q2	$1K	Sell	263 -45	-15%	-$196	﹤0.01%	4711
2022 Q1	$2K	Buy	+308	New	+$1.73K	﹤0.01%	4514
2021 Q3	–	Sell	-27	Closed	–	–	4721
2021 Q2	$0	Buy	+27	New	+$308	﹤0.01%	4612

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CAPTRUST Financial Advisors's NUVB Position: Q1 2026 in Review

CAPTRUST Financial Advisors reduced its Nuvation Bio (NUVB) stake by 2.5% in Q1 2026, selling an estimated $3.94K and leaving 27,751 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #2784.

CAPTRUST Financial Advisors first reported a position in NUVB in Q2 2021 and has held it in 7 quarters since. The position peaked at $255K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

CAPTRUST Financial Advisors held 27,751 shares of Nuvation Bio worth $119K as of Q1 2026.
CAPTRUST Financial Advisors sold 708 Nuvation Bio shares in Q1 2026, an estimated $3.94K.
Nuvation Bio made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2784 holding.
CAPTRUST Financial Advisors first reported a position in Nuvation Bio in Q2 2021 and has held it in 7 quarters since.
CAPTRUST Financial Advisors's Nuvation Bio position peaked at $255K in Q4 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.